Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells

FEMS Immunology and Medical Microbiology

Volumn 61, Issue 1, 2011, Pages 63-75

  Torgersen, Maria L ^a,b   Engedal, Nikolai ^a,b   Pedersen, Anne Mari G ^a,b   Husebye, Harald ^c   Espevik, Terje ^c   Sandvig, Kirsten ^a,b,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

Author keywords

Endothelial cells; Globotriaosylceramide; Retrograde transport; Shiga toxin; Toll like receptor 4

Indexed keywords

GLOBOTRIAOSYLCERAMIDE; SHIGA TOXIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR 4;

ARTICLE; CARCINOMA CELL; CELL LEVEL; CELL SURFACE; COLON CARCINOMA; ENDOSOME; EPITHELIUM CELL; HUMAN; HUMAN CELL; INNATE IMMUNITY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TRANS GOLGI NETWORK; UMBILICAL VEIN ENDOTHELIAL CELL;

CELL LINE, TUMOR; COLORECTAL NEOPLASMS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GOLGI APPARATUS; HUMANS; PROTEIN BINDING; PROTEIN TRANSPORT; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; SHIGA TOXIN; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRIHEXOSYLCERAMIDES; UMBILICAL VEINS;

EID: 78651067675     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2010.00749.x     Document Type: Article

References (52)

1. Arab S & Lingwood CA (1996) Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes. Glycoconj J 13: 159-166.
2. Bhattacharjee RN, Park KS, Okada K, Kumagai Y, Uematsu S, Takeuchi O, Akira S, Iida T & Honda T (2005) Microarray analysis identifies apoptosis regulatory gene expression in HCT116 cells infected with thermostable direct hemolysin-deletion mutant of Vibrio parahaemolyticus. Biochem Bioph Res Co 335: 328-334.
3. Calderwood SK, Theriault J, Gray PJ & Gong J (2007) Cell surface receptors for molecular chaperones. Methods 43: 199-206.
4. Chakrabandhu K, Huault S, Garmy N, Fantini J, Stebe E, Mailfert S, Marguet D & Hueber AO (2008) The extracellular glycosphingolipid-binding motif of Fas defines its internalization route, mode and outcome of signals upon activation by ligand. Cell Death Differ 15: 1824-1837.
5. Chassin C, Vimont S, Cluzeaud F et al. (2008) TLR4 facilitates translocation of bacteria across renal collecting duct cells. J Am Soc Nephrol 19: 2364-2374.
6. Dauphinee SM & Karsan A (2006) Lipopolysaccharide signaling in endothelial cells. Lab Invest 86: 9-22.
7. De Rosa MF, Ackerley C, Wang B, Ito S, Clarke DM & Lingwood C (2008) Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog. J Biol Chem 283: 4501-4511.
8. Engedal N, Skotland T, Torgersen ML & Sandvig K (2010) Shiga toxin and its use in targeted cancer therapy and imaging. Microbial Biotechnol, in press, DOI: DOI: 10.1111/j.1751-7915.2010.00180.x.
9. Falguières T, Maak M, von Weyhern C, Sarr M, Sastre X, Poupon MF, Robine S, Johannes L & Janssen KP (2008) Human colorectal tumors and metastases express Gb3 and can be targeted by an intestinal pathogen-based delivery tool. Mol Cancer Ther 7: 2498-2508.
10. Farkas-Himsley H, Hill R, Rosen B, Arab S & Lingwood CA (1995) The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1. P Natl Acad Sci USA 92: 6996-7000.
11. Fischer H, Ellström P, Ekström K, Gustafsson L, Gustafsson M & Svanborg C (2007) Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol 9: 1239-1251.
12. Gehrmann M, Liebisch G, Schmitz G, Anderson R, Steinem C, De Maio A, Pockley G & Multhoff G (2008) Tumor-specific Hsp70 plasma membrane localization is enabled by the glycosphingolipid Gb3. PLoS ONE 3: e1925.
13. Gribar SC, Richardson WM, Sodhi CP & Hackam DJ (2008) No longer an innocent bystander: epithelial toll-like receptor signaling in the development of mucosal inflammation. Mol Med 14: 645-659.
14. Holmes EH, Hakomori S & Ostrander GK (1987) Synthesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed beta 1-3N-acetylglucosaminyltransferase. J Biol Chem 262: 15649-15658.
15. Huang B, Zhao J, Unkeless JC, Feng ZH & Xiong H (2008) TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 27: 218-224.
16. Hughes AK, Stricklett PK, Schmid D & Kohan DE (2000) Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int 57: 2350-2359.
17. Husebye H, Halaas Ø, Stenmark H, Tunheim G, Sandanger Ø, Bogen B, Brech A, Latz E & Espevik T (2006) Endocytic pathways regulate Toll-like receptor 4 signaling and link innate and adaptive immunity. EMBO J 25: 683-692.
18. Johannes L & Romer W (2010) Shiga toxins - from cell biology to biomedical applications. Nat Rev Microbiol 8: 105-116.
19. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, Bonder C, James WG, Robbins SM & Kubes P (2004) TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J Immunol 173: 7070-7077.
20. Khan F, Proulx F & Lingwood CA (2009) Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. Kidney Int 75: 1209-1216.
21. LaCasse EC, Bray MR, Patterson B et al. (1999) Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation. Blood 94: 2901-2910.
22. Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT & Espevik T (2002) Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction. J Biol Chem 277: 47834-47843.
23. Ling H, Boodhoo A, Hazes B, Cummings MD, Armstrong GD, Brunton JL & Read RJ (1998) Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37: 1777-1788.
24. Lingwood CA (1994) Verotoxin-binding in human renal sections. Nephron 66: 21-28.
25. Lingwood CA (1999) Verotoxin/globotriaosyl ceramide recognition: angiopathy, angiogenesis and antineoplasia. Bioscience Rep 19: 345-354.
26. Mahfoud R, Garmy N, Maresca M, Yahi N, Puigserver A & Fantini J (2002) Identification of a common sphingolipid-binding domain in Alzheimer, prion, and HIV-1 proteins. J Biol Chem 277: 11292-11296.
27. Mangeney M, Richard Y, Coulaud D, Tursz T & Wiels J (1991) CD77: an antigen of germinal center B cells entering apoptosis. Eur J Immunol 21: 1131-1140.
28. Miyamoto Y, Iimura M, Kaper JB, Torres AG & Kagnoff MF (2006) Role of shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo. Cell Microbiol 8: 869-879.
29. Nyholm PG, Magnusson G, Zheng Z, Norel R, Binnington-Boyd B & Lingwood CA (1996) Two distinct binding sites for globotriaosyl ceramide on verotoxins: identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins. Chem Biol 3: 263-275.
30. Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, Nelson MT, Sato S & Obrig TG (2008) Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons. J Infect Dis 198: 1398-1406.
31. Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L & Daniel TO (1993) Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268: 15484-15488.
32. Otte JM, Cario E & Podolsky DK (2004) Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells. Gastroenterology 126: 1054-1070.
33. Pellizzari A, Pang H & Lingwood CA (1992) Binding of verocytotoxin 1 to its receptor is influenced by differences in receptor fatty acid content. Biochemistry 31: 1363-1370.
34. Sandvig K, Garred Ø, Prydz K, Kozlov JV, Hansen SH & van Deurs B (1992) Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358: 510-512.
35. Sandvig K, Bergan J, Dyve AB, Skotland T & Torgersen ML (2010) Endocytosis and retrograde transport of Shiga toxin. Toxicon 58: 1181-1185.
36. Sandvig K, Torgersen ML, Engedal N, Skotland T & Iversen TG (2010) Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine. FEBS Lett 584: 2626-2634.
37. Schuller S, Heuschkel R, Torrente F, Kaper JB & Phillips AD (2007) Shiga toxin binding in normal and inflamed human intestinal mucosa. Microbes Infect 9: 35-39.
38. Shimizu T, Hamabata T, Yoshiki A, Hori T, Ito S, Takeda Y & Hayashi H (2003) An association of 27- and 40-kDa molecules with glycolipids that bind A-B bacterial enterotoxins to cultured cells. Biochim Biophys Acta 1612: 186-194.
39. Siegler RL, Pysher TJ, Lou R, Tesh VL & Taylor FB Jr (2001) Response to shiga toxin-1, with and without lipopolysaccharide, in a primate model of hemolytic uremic syndrome. Am J Nephrol 21: 420-425.
40. Simiantonaki N, Kurzik-Dumke U, Karyofylli G, Jayasinghe C, Michel-Schmidt R & Kirkpatrick CJ (2007) Reduced expression of TLR4 is associated with the metastatic status of human colorectal cancer. Int J Mol Med 20: 21-29.
41. Stone MK, Kolling GL, Lindner MH & Obrig TG (2008) p38 mitogen-activated protein kinase mediates lipopolysaccharide and tumor necrosis factor alpha induction of shiga toxin 2 sensitivity in human umbilical vein endothelial cells. Infect Immun 76: 1115-1121.
42. Suzuki M, Hisamatsu T & Podolsky DK (2003) Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun 71: 3503-3511.
43. Talreja J, Kabir MH, Filla B, Stechschulte DJ & Dileepan KN (2004) Histamine induces toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology 113: 224-233.
44. Tarrago-Trani MT & Storrie B (2007) Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. Adv Drug Deliver Rev 59: 782-797.
45. Torgersen ML, Wälchli S, Grimmer S, Skånland SS & Sandvig K (2007) Protein kinase C delta is activated by Shiga toxin and regulates its transport. J Biol Chem 282: 16317-16328.
46. van de Kar NC, Monnens LA, Karmali MA & van Hinsbergh VW (1992) Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 80: 2755-2764.
47. van Setten PA, van Hinsbergh VW, van der Velden TJ, van de Kar NC, Vermeer M, Mahan JD, Assmann KJ, van Den Heuvel LP & Monnens LA (1997) Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 51: 1245-1256.
48. Yang H, Young DW, Gusovsky F & Chow JC (2000) Cellular events mediated by lipopolysaccharide-stimulated toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 275: 20861-20866.
49. Yoo JW, Hong SW, Kim S & Lee DK (2006) Inflammatory cytokine induction by siRNAs is cell type- and transfection reagent-specific. Biochem Bioph Res Co 347: 1053-1058.
50. Yuhas Y, Weizman A, Dinari G & Ashkenazi S (1995) An animal model for the study of neurotoxicity of bacterial products and application of the model to demonstrate that Shiga toxin and lipopolysaccharide cooperate in inducing neurologic disorders. J Infect Dis 171: 1244-1249.
51. Zhao L, Kwon MJ, Huang S, Lee JY, Fukase K, Inohara N & Hwang DH (2007) Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. J Biol Chem 282: 11618-11628.
52. Zhou M, Farland-Mancini MM, Funk HM, Husseinzadeh N, Mounajjed T & Drew AF (2009) Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol Immun 58: 1375-1385.